Herbal medicines in the treatment of coronavirus disease 2019 (COVID-19)

Herbal medicines in the treatment of coronavirus disease 2019 (COVID-19)

Coronavirus disease 2019 (COVID-19), caused by a novel coronavirus, started in livestock within the markets of Wuhan, China and was consequently spread around the world. The virus has been rapidly spread worldwide due to the outbreak. COVID-19 is the third serious coronavirus outbreak in less than 2...

Full description

Bibliographic Details
Main Authors:	Audrey Tolouian, Maryam Khosravian, Hedieh Ragati Haghi, Alireza Bolourian, Zahra Mojtahedi, Masoumeh Asgharpour, Amirhesam Alirezaei
Format:	Article
Language:	English
Published:	Society of Diabetic Nephropathy Prevention 2021-05-01
Series:	Journal of Nephropharmacology
Subjects:	covid-19 herbal medicines flavonoids angiotensin-converting enzyme 2 coronavirus disease 2019
Online Access:	https://jnephropharmacology.com/PDF/npj-10374

Similar Items

The Potential of the Use of the Flavonoid Fisetin in the Treatment of Coronavirus by Inhibition of Angiotensin Converting Enzyme 2
by: Seyedeh Sara Azadeh, et al.
Published: (2021-11-01)

Herbal antioxidants in dialysis patients: a review of potential mechanisms and medical implications
by: Masoumeh Asgharpour, et al.
Published: (2021-01-01)

Coronavirus disease 2019 and cardiovascular disease
by: Jenn-Yeu Song, et al.
Published: (2023-01-01)

Diminazene Aceturate Reduces Angiotensin II Constriction and Interacts with the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2
by: John M. Matsoukas, et al.
Published: (2022-07-01)

Can coronavirus disease 2019 effect on human reproduction?
by: Ali Abdolrazaghnejad, et al.
Published: (2022-01-01)

Potential adverse effects of coronavirus disease 2019 on the cardiovascular system
by: Bing-Yin Wang, et al.
Published: (2021-01-01)

Role of Angiotensin II in Cardiovascular Diseases: Introducing Bisartans as a Novel Therapy for Coronavirus 2019
by: Jordan Swiderski, et al.
Published: (2023-05-01)

Renin-angiotensin system in the pathogenesis of COVID-19 and possible drug targets
by: Sujay Halkur Shankar, et al.
Published: (2021-01-01)

Phytoconstituents profiling of indigenous herbal drugs and its in vitro microbial, in silico biological examination against Severe acute respiratory syndrome coronavirus 2
by: T H. Mohamed Ahadu Shareef, et al.
Published: (2024-01-01)

Associations Between the Use of Renin–Angiotensin System Inhibitors and the Risks of Severe COVID-19 and Mortality in COVID-19 Patients With Hypertension: A Meta-Analysis of Observational Studies
by: Xiao-Ce Dai, et al.
Published: (2021-04-01)

Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19
by: Naci Şenkal, et al.
Published: (2020-07-01)

Updates on coronavirus (COVID-19) and kidney
by: Seyed Zanyar Athari, et al.
Published: (2020-10-01)

Lung cancer and kidney injury: an updated review
by: Bhargav Patel, et al.
Published: (2021-04-01)

Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
by: Rami Sommerstein, et al.
Published: (2020-04-01)

Neuronal and Cerebrovascular Complications in Coronavirus Disease 2019
by: Mudasir S. Andrabi, et al.
Published: (2020-11-01)

Meta-analysis of the association between angiotensin pathway inhibitors and COVID-19 severity and mortality
by: Malindu E. Fernando, et al.
Published: (2021-09-01)

Coronavirus disease 2019 gastrointestinal and liver manifestations in adults: A review
by: Apichet Sirinawasatien, et al.
Published: (2021-11-01)

Potential use of the S-protein–Angiotensin converting enzyme 2 binding pathway in the treatment of coronavirus disease 2019
by: Long Feng, et al.
Published: (2022-11-01)

Research Progress of Genetic Structure, Pathogenic Mechanism, Clinical Characteristics, and Potential Treatments of Coronavirus Disease 2019
by: Chunsheng Zhu, et al.
Published: (2020-08-01)

Herbal medicine for the management of COVID-19 during the medical observation period: a review of guidelines
by: Lin Ang, et al.
Published: (2020-09-01)

The efficacy and safety of sitagliptin administration in patients with Covid-19: A randomized clinical trial
by: Nahid Etemadi Toudeshki, et al.
Published: (2023-01-01)

Recent advance of ACE2 and microbiota dysfunction in COVID-19 pathogenesis
by: Zhidan Yu, et al.
Published: (2021-07-01)

Unraveling the Link between Periodontitis and Coronavirus Disease 2019: Exploring Pathogenic Pathways and Clinical Implications
by: En-Chin Lin, et al.
Published: (2023-10-01)

Effects of renin-angiotensin system blockers on the risk and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with hypertension
by: Jinwoo Lee, et al.
Published: (2021-03-01)

Decreased Heart Rate Variability in COVID-19
by: Chengfen Yin, et al.
Published: (2022-12-01)

Oral and Periodontal Manifestations of COVID-19 and its Plausible Association with Periodontal Disease
by: Narayane Ramkumar, et al.
Published: (2021-08-01)

Chronic Obstructive Pulmonary Disease and COVID-19: A Double Trouble
by: Jyoti Bajpai, et al.
Published: (2021-11-01)

Discovery of Clioquinol and analogues as novel inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 infection, ACE2 and ACE2 - Spike protein interaction in vitro
by: Omonike A. Olaleye, et al.
Published: (2021-03-01)

Effects of Iranian herbal Zofa® syrup for the management of clinical symptoms in patients with COVID-19: A randomized clinical trial
by: Ali Ghazvini, et al.
Published: (2023-09-01)

Effects of the COVID‐19 pandemic on heart failure hospitalizations in Japan: interrupted time series analysis
by: Tetsuji Morishita, et al.
Published: (2022-02-01)

Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
by: Enrique Ambrocio-Ortiz, et al.
Published: (2021-08-01)

Understanding kidney injury in COVID-19; a pressing priority
by: Elham Ahmadipour, et al.
Published: (2021-05-01)

Coronavirus disease and male fertility: a systematic review
by: Mobina Fathi, et al.
Published: (2021-08-01)

Strategies and Advances in Combating COVID-19 in China
by: Wei Liu, et al.
Published: (2020-10-01)

Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines
by: Lin Ang, et al.
Published: (2020-06-01)

Current Prevention of COVID-19: Natural Products and Herbal Medicine
by: Junqing Huang, et al.
Published: (2020-10-01)

Pathophysiological mechanisms of coronavirus disease (COVID-19) progression and fatal complications in patients with diabetes
by: T. O. Briukhanova, et al.
Published: (2020-10-01)

Are angiotensin converting enzyme (ACE1/ACE2) gene variants associated with the clinical severity of COVID-19 pneumonia? A singlecenter cohort study
by: Serdal Baştuğ, et al.
Published: (2022-02-01)

Paying Attention to Circadian Rhythms in the Treatment of COVID-19
by: Atefeh Bakhtazad, et al.
Published: (2020-04-01)

Plasma Angiotensin II Is Increased in Critical Coronavirus Disease 2019
by: Rafael L. Camargo, et al.
Published: (2022-06-01)